TORONTO, Sep 10, 2009 (BUSINESS WIRE) -- Biovail Corporation (NYSE, TSX: BVF) today announced that the Company will participate at the Thomas Weisel Partners (TWP) Healthcare Conference in Boston, MA; and at the Morgan Stanley Global Healthcare Conference and the UBS Global Life Sciences Conference in New York, NY.
Biovail's presentation at the TWP conference is scheduled for Friday, September 11, 2009 at 10:55 am ET. The Morgan Stanley conference presentation is scheduled for Monday, September 14, 2009 at 8:35 am ET. The UBS Conference presentation is scheduled for Monday, September 21, 2009 at 1:00 pm ET. Live and archived webcasts of these presentations will be available on the Investor Relations page of Biovail's Web site at www.biovail.com.
About Biovail Corporation
Biovail Corporation is a specialty pharmaceutical company engaged in the formulation, clinical testing, registration, manufacture, and commercialization of pharmaceutical products. The Company is focused on the development and commercialization of medicines that address unmet medical needs in niche specialty central nervous system (CNS) markets. For more information about Biovail, visit the Company's Web site at www.biovail.com.
For further information, please contact Nelson F. Isabel at 905-286-3000 or send inquiries to [email protected].
SOURCE: Biovail Corporation
Biovail Corporation
Nelson F. Isabel, 905-286-3000
Vice President, Investor Relations &
Corporate Communications
